Literature DB >> 33416080

IDH glioma radiogenomics in the era of deep learning.

David C Gutman1,2, Robert J Young1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33416080      PMCID： PMC7906046          DOI： 10.1093/neuonc/noaa294

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN： 1522-8517            Impact factor:   12.300


× No keyword cloud information.
  7 in total

Review 1.  Deep learning.

Authors:  Yann LeCun; Yoshua Bengio; Geoffrey Hinton
Journal:  Nature       Date:  2015-05-28       Impact factor: 49.962

2.  Prediction of IDH genotype in gliomas with dynamic susceptibility contrast perfusion MR imaging using an explainable recurrent neural network.

Authors:  Kyu Sung Choi; Seung Hong Choi; Bumseok Jeong
Journal:  Neuro Oncol       Date:  2019-05-24       Impact factor: 12.300

3.  A novel fully automated MRI-based deep-learning method for classification of IDH mutation status in brain gliomas.

Authors:  Chandan Ganesh Bangalore Yogananda; Bhavya R Shah; Maryam Vejdani-Jahromi; Sahil S Nalawade; Gowtham K Murugesan; Frank F Yu; Marco C Pinho; Benjamin C Wagner; Bruce Mickey; Toral R Patel; Baowei Fei; Ananth J Madhuranthakam; Joseph A Maldjian
Journal:  Neuro Oncol       Date:  2020-03-05       Impact factor: 12.300

4.  Fully automated hybrid approach to predict the IDH mutation status of gliomas via deep learning and radiomics.

Authors:  Yoon Seong Choi; Sohi Bae; Jong Hee Chang; Seok-Gu Kang; Se Hoon Kim; Jinna Kim; Tyler Hyungtaek Rim; Seung Hong Choi; Rajan Jain; Seung-Koo Lee
Journal:  Neuro Oncol       Date:  2021-02-25       Impact factor: 12.300

5.  Integration of 2-hydroxyglutarate-proton magnetic resonance spectroscopy into clinical practice for disease monitoring in isocitrate dehydrogenase-mutant glioma.

Authors:  Macarena I de la Fuente; Robert J Young; Jennifer Rubel; Marc Rosenblum; Jamie Tisnado; Samuel Briggs; Julio Arevalo-Perez; Justin R Cross; Carl Campos; Kimberly Straley; Dongwei Zhu; Chuanhui Dong; Alissa Thomas; Antonio A Omuro; Craig P Nolan; Elena Pentsova; Thomas J Kaley; Jung H Oh; Ralph Noeske; Elizabeth Maher; Changho Choi; Philip H Gutin; Andrei I Holodny; Katharine Yen; Lisa M DeAngelis; Ingo K Mellinghoff; Sunitha B Thakur
Journal:  Neuro Oncol       Date:  2015-12-20       Impact factor: 12.300

6.  The T2-FLAIR mismatch sign as an imaging marker for non-enhancing IDH-mutant, 1p/19q-intact lower-grade glioma: a validation study.

Authors:  Martinus P G Broen; Marion Smits; Maarten M J Wijnenga; Hendrikus J Dubbink; Monique H M E Anten; Olaf E M G Schijns; Jan Beckervordersandforth; Alida A Postma; Martin J van den Bent
Journal:  Neuro Oncol       Date:  2018-09-03       Impact factor: 13.029

7.  Highly specific determination of IDH status using edited in vivo magnetic resonance spectroscopy.

Authors:  Francesca Branzoli; Anna Luisa Di Stefano; Laurent Capelle; Chris Ottolenghi; Romain Valabrègue; Dinesh K Deelchand; Franck Bielle; Chiara Villa; Bertrand Baussart; Stéphane Lehéricy; Marc Sanson; Malgorzata Marjanska
Journal:  Neuro Oncol       Date:  2018-06-18       Impact factor: 13.029
  7 in total
  2 in total

Review 1.  Role of Artificial Intelligence in Radiogenomics for Cancers in the Era of Precision Medicine.

Authors:  Sanjay Saxena; Biswajit Jena; Neha Gupta; Suchismita Das; Deepaneeta Sarmah; Pallab Bhattacharya; Tanmay Nath; Sudip Paul; Mostafa M Fouda; Manudeep Kalra; Luca Saba; Gyan Pareek; Jasjit S Suri
Journal:  Cancers (Basel)       Date:  2022-06-09       Impact factor: 6.575

2.  Swin Transformer Improves the IDH Mutation Status Prediction of Gliomas Free of MRI-Based Tumor Segmentation.

Authors:  Jiangfen Wu; Qian Xu; Yiqing Shen; Weidao Chen; Kai Xu; Xian-Rong Qi
Journal:  J Clin Med       Date:  2022-08-08       Impact factor: 4.964
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.